
Quest Diagnostics (DGX) Financial Statements
Price: $165.83
Market Cap: $18.40B
Avg Volume: 1.14M
Market Cap: $18.40B
Avg Volume: 1.14M
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Quest Diagnostics.
Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.71B | $7.51B | $7.49B |
Cost of Revenue | $6.63B | $6.29B | $6.45B | $6.58B | $5.80B | $5.04B | $4.93B | $4.72B | $4.62B | $4.66B |
Gross Profit | $3.24B | $2.96B | $3.43B | $4.21B | $3.63B | $2.69B | $2.60B | $2.99B | $2.90B | $2.84B |
Gross Profit Ratio | 32.86% | 32.00% | 34.74% | 39.02% | 38.50% | 34.80% | 34.59% | 38.79% | 38.58% | 37.85% |
Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $1.42B | $1.75B | $1.68B | $1.68B |
Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $1.77B | $1.61B | $1.87B | $1.73B | $1.55B | $1.46B | $1.42B | $1.75B | $1.68B | $1.68B |
Other Expenses | $128.00M | $- | $131.00M | $101.00M | $112.00M | $1.00M | $-8.00M | $16.00M | $-48.00M | $-143.00M |
Operating Expenses | $1.93B | $1.76B | $2.00B | $1.83B | $1.66B | $1.46B | $1.50B | $1.82B | $1.74B | $1.77B |
Cost and Expenses | $8.53B | $7.99B | $8.46B | $8.41B | $7.47B | $6.50B | $6.43B | $6.54B | $6.36B | $6.43B |
Interest Income | $25.00M | $11.00M | $10.00M | $1.00M | $3.00M | $5.00M | $2.00M | $2.00M | $1.00M | $1.00M |
Interest Expense | $226.00M | $163.00M | $138.00M | $151.00M | $163.00M | $175.00M | $167.00M | $151.00M | $143.00M | $153.00M |
Depreciation and Amortization | $493.00M | $439.00M | $437.00M | $408.00M | $361.00M | $329.00M | $309.00M | $270.00M | $249.00M | $304.00M |
EBITDA | $1.91B | $1.73B | $1.82B | $3.16B | $2.41B | $1.58B | $1.40B | $1.45B | $1.48B | $1.55B |
EBITDA Ratio | 19.34% | 18.72% | 18.42% | 29.28% | 25.55% | 20.52% | 18.64% | 18.85% | 19.68% | 20.75% |
Operating Income | $1.35B | $1.26B | $1.43B | $2.38B | $1.97B | $1.23B | $1.10B | $1.17B | $1.28B | $1.40B |
Operating Income Ratio | 13.63% | 13.64% | 14.45% | 22.07% | 20.89% | 15.93% | 14.62% | 15.11% | 16.99% | 18.67% |
Total Other Income Expenses Net | $-171.00M | $-132.00M | $-193.00M | $218.00M | $-87.00M | $-155.00M | $-175.00M | $-135.00M | $-142.00M | $-101.00M |
Income Before Tax | $1.18B | $1.13B | $1.24B | $2.60B | $1.88B | $1.08B | $926.00M | $1.03B | $1.09B | $1.10B |
Income Before Tax Ratio | 11.90% | 12.21% | 12.50% | 24.09% | 19.96% | 13.93% | 12.30% | 13.36% | 14.45% | 14.72% |
Income Tax Expense | $273.00M | $248.00M | $264.00M | $597.00M | $460.00M | $247.00M | $182.00M | $241.00M | $429.00M | $373.00M |
Net Income | $871.00M | $854.00M | $946.00M | $2.00B | $1.43B | $858.00M | $736.00M | $772.00M | $645.00M | $709.00M |
Net Income Ratio | 8.82% | 9.23% | 9.57% | 18.49% | 15.16% | 11.11% | 9.77% | 10.01% | 8.58% | 9.46% |
EPS | $7.80 | $7.59 | $8.12 | $15.90 | $10.68 | $6.38 | $5.41 | $5.63 | $4.58 | $4.92 |
EPS Diluted | $7.66 | $7.52 | $7.98 | $15.53 | $10.52 | $6.29 | $5.29 | $5.50 | $4.51 | $4.87 |
Weighted Average Shares Outstanding | 111.00M | 112.00M | 116.00M | 125.00M | 134.00M | 134.00M | 136.00M | 137.00M | 140.00M | 144.00M |
Weighted Average Shares Outstanding Diluted | 113.00M | 113.00M | 118.00M | 128.00M | 136.00M | 136.00M | 139.00M | 140.00M | 142.00M | 145.00M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $549.00M | $686.00M | $315.00M | $872.00M | $1.16B | $1.19B | $135.00M | $137.00M | $359.00M | $133.00M |
Short Term Investments | $- | $- | $- | $44.00M | $- | $- | $- | $- | $- | $- |
Cash and Short Term Investments | $549.00M | $686.00M | $315.00M | $872.00M | $1.16B | $1.19B | $135.00M | $137.00M | $359.00M | $133.00M |
Net Receivables | $1.30B | $1.21B | $1.20B | $1.44B | $1.52B | $1.06B | $1.01B | $924.00M | $926.00M | $901.00M |
Inventory | $188.00M | $190.00M | $192.00M | $208.00M | $223.00M | $123.00M | $99.00M | $95.00M | $82.00M | $84.00M |
Other Current Assets | $351.00M | $286.00M | $196.00M | $223.00M | $157.00M | $112.00M | $144.00M | $150.00M | $164.00M | $383.00M |
Total Current Assets | $2.39B | $2.37B | $1.90B | $2.74B | $3.06B | $2.49B | $1.39B | $1.31B | $1.53B | $1.50B |
Property Plant Equipment Net | $2.76B | $2.42B | $2.35B | $2.30B | $2.23B | $1.97B | $1.29B | $1.15B | $1.03B | $925.00M |
Goodwill | $8.86B | $7.73B | $7.22B | $7.09B | $6.87B | $6.62B | $6.56B | $6.33B | $6.00B | $5.91B |
Intangible Assets | $1.76B | $1.17B | $1.09B | $1.17B | $1.17B | $1.12B | $1.21B | $1.12B | $949.00M | $984.00M |
Goodwill and Intangible Assets | $10.62B | $8.90B | $8.31B | $8.26B | $8.04B | $7.74B | $7.77B | $7.45B | $6.95B | $6.89B |
Long Term Investments | $123.00M | $135.00M | $132.00M | $141.00M | $521.00M | $482.00M | $436.00M | $462.00M | $443.00M | $473.00M |
Tax Assets | $- | $- | $- | $- | $- | $- | $- | $4.00M | $32.00M | $- |
Other Non-Current Assets | $255.00M | $198.00M | $144.00M | $163.00M | $176.00M | $160.00M | $119.00M | $132.00M | $116.00M | $174.00M |
Total Non-Current Assets | $13.76B | $11.65B | $10.94B | $10.87B | $10.97B | $10.35B | $9.61B | $9.20B | $8.57B | $8.46B |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B |
Account Payables | $1.39B | $378.00M | $324.00M | $357.00M | $446.00M | $263.00M | $222.00M | $224.00M | $231.00M | $279.00M |
Short Term Debt | $775.00M | $456.00M | $247.00M | $269.00M | $296.00M | $1.04B | $562.00M | $107.00M | $36.00M | $159.00M |
Tax Payables | $- | $- | $2.00M | $10.00M | $43.00M | $27.00M | $17.00M | $9.00M | $3.00M | $4.00M |
Deferred Revenue | $- | $516.00M | $- | $- | $- | $- | $17.00M | $80.00M | $3.00M | $4.00M |
Other Current Liabilities | $- | $981.00M | $978.00M | $1.12B | $991.00M | $663.00M | $684.00M | $717.00M | $711.00M | $731.00M |
Total Current Liabilities | $2.17B | $1.81B | $1.55B | $1.75B | $1.78B | $1.99B | $1.49B | $1.06B | $981.00M | $1.17B |
Long Term Debt | $6.15B | $4.91B | $4.47B | $4.50B | $4.51B | $4.38B | $3.52B | $3.75B | $3.82B | $3.50B |
Deferred Revenue Non-Current | $- | $- | $-295.00M | $-290.00M | $-350.00M | $-264.00M | $-243.00M | $-170.00M | $-191.00M | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $295.00M | $290.00M | $350.00M | $264.00M | $243.00M | $170.00M | $191.00M | $- |
Other Non-Current Liabilities | $938.00M | $876.00M | $812.00M | $792.00M | $847.00M | $711.00M | $652.00M | $663.00M | $566.00M | $508.00M |
Total Non-Current Liabilities | $7.09B | $5.79B | $5.28B | $5.30B | $5.36B | $5.09B | $4.17B | $4.41B | $4.38B | $4.01B |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $9.26B | $7.60B | $6.83B | $7.05B | $7.13B | $7.08B | $5.66B | $5.47B | $5.36B | $5.18B |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
Retained Earnings | $9.36B | $8.82B | $8.29B | $7.65B | $9.30B | $8.17B | $7.60B | $7.14B | $6.61B | $6.20B |
Accumulated Other Comprehensive Income Loss | $-88.00M | $-14.00M | $-21.00M | $-14.00M | $-21.00M | $-39.00M | $-59.00M | $-48.00M | $-72.00M | $-38.00M |
Other Total Stockholders Equity | $-2.50B | $-2.51B | $-2.38B | $-1.19B | $-2.52B | $-2.50B | $-2.33B | $-2.17B | $-1.92B | $-1.48B |
Total Stockholders Equity | $6.78B | $6.31B | $5.89B | $6.44B | $6.76B | $5.64B | $5.22B | $4.92B | $4.63B | $4.68B |
Total Equity | $6.90B | $6.42B | $6.01B | $6.56B | $6.89B | $5.76B | $5.34B | $5.04B | $4.74B | $4.78B |
Total Liabilities and Stockholders Equity | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B |
Minority Interest | $118.00M | $111.00M | $114.00M | $118.00M | $132.00M | $122.00M | $128.00M | $114.00M | $109.00M | $99.00M |
Total Liabilities and Total Equity | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B |
Total Investments | $123.00M | $135.00M | $132.00M | $141.00M | $521.00M | $482.00M | $436.00M | $462.00M | $443.00M | $473.00M |
Total Debt | $6.92B | $5.50B | $4.62B | $4.66B | $4.66B | $5.33B | $3.89B | $3.78B | $3.73B | $3.65B |
Net Debt | $6.38B | $4.81B | $4.31B | $3.79B | $3.50B | $4.14B | $3.76B | $3.65B | $3.38B | $3.52B |
Cash Flow Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | $921.00M | $908.00M | $1.01B | $2.08B | $1.50B | $906.00M | $788.00M | $824.00M | $696.00M | $753.00M |
Depreciation and Amortization | $493.00M | $439.00M | $437.00M | $408.00M | $361.00M | $329.00M | $309.00M | $270.00M | $249.00M | $304.00M |
Deferred Income Tax | $13.00M | $-49.00M | $1.00M | $-57.00M | $85.00M | $15.00M | $73.00M | $9.00M | $37.00M | $112.00M |
Stock Based Compensation | $88.00M | $77.00M | $77.00M | $79.00M | $97.00M | $56.00M | $61.00M | $79.00M | $69.00M | $52.00M |
Change in Working Capital | $-201.00M | $-145.00M | $119.00M | $87.00M | $22.00M | $35.00M | $-49.00M | $-316.00M | $-166.00M | $-375.00M |
Accounts Receivables | $-71.00M | $-15.00M | $246.00M | $81.00M | $-455.00M | $-63.00M | $-65.00M | $-298.00M | $-343.00M | $-262.00M |
Inventory | $- | $- | $- | $-20.00M | $- | $29.00M | $4.00M | $16.00M | $42.00M | $-41.00M |
Accounts Payables | $-67.00M | $-55.00M | $-149.00M | $35.00M | $452.00M | $73.00M | $-19.00M | $-8.00M | $56.00M | $-31.00M |
Other Working Capital | $-63.00M | $-75.00M | $22.00M | $-9.00M | $3.00M | $-4.00M | $31.00M | $-26.00M | $79.00M | $-41.00M |
Other Non Cash Items | $20.00M | $42.00M | $69.00M | $-364.00M | $-59.00M | $-98.00M | $18.00M | $309.00M | $184.00M | $-36.00M |
Net Cash Provided by Operating Activities | $1.33B | $1.27B | $1.72B | $2.23B | $2.00B | $1.24B | $1.20B | $1.18B | $1.07B | $810.00M |
Investments in Property Plant and Equipment | $-425.00M | $-408.00M | $-404.00M | $-403.00M | $-418.00M | $-400.00M | $-383.00M | $-252.00M | $-293.00M | $-263.00M |
Acquisitions Net | $-2.16B | $-611.00M | $-144.00M | $424.00M | $-330.00M | $-58.00M | $-419.00M | $-555.00M | $131.00M | $-100.00M |
Purchases of Investments | $- | $- | $-5.00M | $-3.00M | $-27.00M | $-44.00M | $383.00M | $252.00M | $293.00M | $263.00M |
Sales Maturities of Investments | $- | $- | $5.00M | $403.00M | $418.00M | $400.00M | $1.00M | $2.00M | $10.00M | $1.00M |
Other Investing Activities | $41.00M | $-42.00M | $5.00M | $-400.00M | $-415.00M | $-309.00M | $-383.00M | $-252.00M | $-293.00M | $-263.00M |
Net Cash Used for Investing Activities | $-2.55B | $-1.06B | $-543.00M | $21.00M | $-772.00M | $-411.00M | $-801.00M | $-805.00M | $-152.00M | $-362.00M |
Debt Repayment | $1.54B | $748.00M | $-2.00M | $-2.00M | $-805.00M | $832.00M | $124.00M | $23.00M | $141.00M | $-84.00M |
Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Repurchased | $-175.00M | $-275.00M | $-1.41B | $-2.20B | $-325.00M | $-353.00M | $-322.00M | $-465.00M | $-590.00M | $-224.00M |
Dividends Paid | $-331.00M | $-314.00M | $-305.00M | $-309.00M | $-297.00M | $-286.00M | $-266.00M | $-247.00M | $-223.00M | $-212.00M |
Other Financing Activities | $47.00M | $1.00M | $-17.00M | $-30.00M | $160.00M | $32.00M | $63.00M | $97.00M | $-19.00M | $2.00M |
Net Cash Used Provided by Financing Activities | $1.08B | $160.00M | $-1.73B | $-2.54B | $-1.27B | $225.00M | $-401.00M | $-592.00M | $-691.00M | $-507.00M |
Effect of Forex Changes on Cash | $-7.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Net Change in Cash | $-137.00M | $371.00M | $-557.00M | $-286.00M | $-34.00M | $1.06B | $-2.00M | $-222.00M | $226.00M | $-59.00M |
Cash at End of Period | $549.00M | $686.00M | $315.00M | $872.00M | $1.16B | $1.19B | $135.00M | $137.00M | $359.00M | $133.00M |
Cash at Beginning of Period | $686.00M | $315.00M | $872.00M | $1.16B | $1.19B | $135.00M | $137.00M | $359.00M | $133.00M | $192.00M |
Operating Cash Flow | $1.33B | $1.27B | $1.72B | $2.23B | $2.00B | $1.24B | $1.20B | $1.18B | $1.07B | $810.00M |
Capital Expenditure | $-425.00M | $-408.00M | $-404.00M | $-403.00M | $-418.00M | $-400.00M | $-383.00M | $-252.00M | $-293.00M | $-263.00M |
Free Cash Flow | $909.00M | $864.00M | $1.31B | $1.83B | $1.59B | $843.00M | $817.00M | $923.00M | $776.00M | $547.00M |